Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 1.3.1.24 - biliverdin reductase

for references in articles please use BRENDA:EC1.3.1.24

Please use the Disease Search for a specific query.

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Alkalosis
The effects of acidosis and alkalosis on long bone vascular resistance.
Alzheimer Disease
Biliverdin reductase as a target in drug research and development: Facts and hypotheses.
Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment.
Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain.
Biliverdin reductase-A impairment links brain insulin resistance with increased A? production in an animal model of aging: Implications for Alzheimer disease.
Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease.
Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease.
Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm.
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease.
Oxidative and nitrosative modifications of biliverdin reductase-a in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment.
Anemia
Bone marrow: its contribution to heme catabolism.
Anemia, Hemolytic
Bone marrow: its contribution to heme catabolism.
Anemia, Iron-Deficiency
Bone marrow: its contribution to heme catabolism.
Anemia, Sickle Cell
Abnormal modulation of cell protective systems in response to ischemic/reperfusion injury is important in the development of mouse sickle cell hepatopathy.
Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease.
Anemia, Sideroblastic
Bone marrow: its contribution to heme catabolism.
Aneurysm
Recurring Thalamic Symptoms Due to Intracranial Dural Arteriovenous Fistula: Report of Unusual Case and Treatment Outcome.
Aortic Aneurysm, Abdominal
Biliverdin reductase deficiency triggers an endothelial-to-mesenchymal transition in human endothelial cells.
Atherosclerosis
Biliverdin reductase as a target in drug research and development: Facts and hypotheses.
Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease.
Plaque fissure: the link between atherosclerosis and thrombosis.
Atrial Fibrillation
Direct oral anticoagulants in patients with atrial fibrillation and bioprosthetic valve replacement: A meta-analysis.
Atrioventricular Block
Beat-to-beat variability of repolarization: a new parameter to determine arrhythmic risk of an individual or identify proarrhythmic drugs.
biliverdin reductase deficiency
Biliverdin reductase deficiency triggers an endothelial-to-mesenchymal transition in human endothelial cells.
Biliverdin Reductase-A Deficiency Brighten and Sensitize Biliverdin-binding Chromoproteins.
BVR-A Deficiency Leads to Autophagy Impairment through the Dysregulation of AMPK/mTOR Axis in the Brain-Implications for Neurodegeneration.
Bradycardia
Proarrhythmic electrical remodelling is associated with increased beat-to-beat variability of repolarisation.
Brain Injuries
Enhanced neuronal expression of the oxidoreductase--biliverdin reductase--after permanent focal cerebral ischemia.
Brain Neoplasms
Oxidant and anti-oxidant status in common brain tumors: Correlation to TP53 and human biliverdin reductase.
Breast Neoplasms
Human biliverdin reductase promotes EMT through the ERK1/2 signal pathway in breast cancer.
Human biliverdin reductase regulates the molecular mechanism underlying cancer development.
Carcinoma
The heme oxygenase/biliverdin reductase system in skin cancers.
The oxidoreductase, biliverdin reductase, is induced in human renal carcinoma--pH and cofactor-specific increase in activity.
Carcinoma, Basal Cell
The heme oxygenase/biliverdin reductase system in skin cancers.
Carcinoma, Hepatocellular
MicroRNA-127-5p targets the biliverdin reductase B/nuclear factor-?B pathway to suppress cell growth in hepatocellular carcinoma cells.
Carcinoma, Renal Cell
The oxidoreductase, biliverdin reductase, is induced in human renal carcinoma--pH and cofactor-specific increase in activity.
Cardiotoxicity
The coordinated increased expression of biliverdin reductase and heme oxygenase-2 promotes cardiomyocyte survival: a reductase-based peptide counters {beta}-adrenergic receptor ligand-mediated cardiac dysfunction.
Cerebral Hemorrhage
[Dural arteriovenous fistula involving the cavernous sinus as the cause of intracerebral venous hemorrhage: a case report]
Chickenpox
Varicella breakthrough infection and effectiveness of 2-dose varicella vaccine in China.
Cholestasis
A homozygous nonsense mutation (c.214C->A) in the biliverdin reductase alpha gene (BLVRA) results in accumulation of biliverdin during episodes of cholestasis.
Role of vitamin C transporters and biliverdin reductase in the dual pro-oxidant and anti-oxidant effect of biliary compounds on the placental-fetal unit in cholestasis during pregnancy.
Colorectal Neoplasms
Biliverdin Reductase A (BLVRA) Promotes Colorectal Cancer Cell Progression by Activating the Wnt/?-Catenin Signaling Pathway.
Coma
Cerebrovascular carbon dioxide reactivity assessed by intracranial pressure dynamics in severely head injured patients.
Death, Sudden, Cardiac
Beat-to-beat variability of repolarization: a new parameter to determine arrhythmic risk of an individual or identify proarrhythmic drugs.
Diabetes Mellitus, Type 2
Biliverdin reductase-A protein levels are reduced in type 2 diabetes and are associated with poor glycometabolic control.
Drug-Related Side Effects and Adverse Reactions
Torsadogenic Drug-induced Increased Short-term Variability of JT-area.
Encephalomyelitis
Biliverdin reductase, a major physiologic cytoprotectant, suppresses experimental autoimmune encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
Biliverdin reductase, a major physiologic cytoprotectant, suppresses experimental autoimmune encephalomyelitis.
Endocardial Fibroelastosis
Fetal Echocardiography in Predicting Postnatal Outcome in Borderline Left Ventricle.
Essential Hypertension
Association of a BLVRA Common Polymorphism with Essential Hypertension and Blood Pressure in Kazaks.
Fatty Liver
Reduced Biliverdin Reductase-A Expression in Visceral Adipose Tissue is Associated with Adipocyte Dysfunction and NAFLD in Human Obesity.
Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity.
Glioblastoma
Biliverdin reductase plays a crucial role in hypoxia-induced chemoresistance in human glioblastoma.
Heart Diseases
Biliverdin reductase as a target in drug research and development: Facts and hypotheses.
Heart Septal Defects, Ventricular
Biventricular repair after Norwood palliation.
Staged Biventricular Repair-Oriented Strategy in Borderline Biventricular Repair Candidates with Ventricular Septal Defect.
Hepatitis
Cell surface biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol 3-kinase and Akt.
Hyperemia
Different effects of beta-1-adrenergic blocking agents with ISA or without ISA on peripheral blood flow.
Extensive basal ganglia edema caused by a traumatic carotid-cavernous fistula: a rare presentation related to a basal vein of Rosenthal anatomical variation.
Hyperglycemia
A critical and comprehensive insight on heme oxygenase and related products including carbon monoxide, bilirubin, biliverdin and ferritin in type-1 and type-2 diabetes.
Hypertension
Extensive basal ganglia edema caused by a traumatic carotid-cavernous fistula: a rare presentation related to a basal vein of Rosenthal anatomical variation.
Infarction, Middle Cerebral Artery
Assessment of induction of biliverdin reductase in a mouse model of middle cerebral artery occlusion.
Enhanced neuronal expression of the oxidoreductase--biliverdin reductase--after permanent focal cerebral ischemia.
Infections
Serial ultrasound assessment of the basal vein of Rosenthal in HSV encephalitis.
Studies on heme and heme oxygenase during Plasmodium berghei infection in golden hamsters.
Insulin Resistance
Biliverdin reductase-A impairment links brain insulin resistance with increased A? production in an animal model of aging: Implications for Alzheimer disease.
Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease.
Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm.
Old biliverdin reductase: links to insulin resistance and may be a novel therapeutic target.
Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity.
Jaundice, Neonatal
Computational and experimental studies on the catalytic mechanism of biliverdin-IXbeta reductase.
The use of synthetic linear tetrapyrroles to probe the verdin sites of human biliverdin-IXalpha reductase and human biliverdin-IXbeta reductase.
Leukemia
Targeting biliverdin reductase overcomes multidrug resistance in leukemia HL60 cells.
Liver Cirrhosis
A novel mutation in the biliverdin reductase-A gene combined with liver cirrhosis results in hyperbiliverdinaemia (green jaundice).
Liver Diseases
A novel mutation in the biliverdin reductase-A gene combined with liver cirrhosis results in hyperbiliverdinaemia (green jaundice).
Reduced Biliverdin Reductase-A Expression in Visceral Adipose Tissue is Associated with Adipocyte Dysfunction and NAFLD in Human Obesity.
Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity.
Liver Neoplasms
Predictive role BLVRA mRNA expression in hepatocellular cancer.
Melanoma
The heme oxygenase/biliverdin reductase system in skin cancers.
Meningioma
Encountering a basal vein of Rosenthal variant during the anterior transpetrosal approach.
Metabolic Syndrome
Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity.
Multiple Sclerosis
Biliverdin reductase, a major physiologic cytoprotectant, suppresses experimental autoimmune encephalomyelitis.
Myocardial Infarction
Microvolt t-wave alternans and beat-to-beat variability of repolarization during early post-ischemic remodeling in a pig heart.
Neoplasms
Biliverdin Reductase A (BLVRA) Promotes Colorectal Cancer Cell Progression by Activating the Wnt/?-Catenin Signaling Pathway.
Biliverdin reductase as a target in drug research and development: Facts and hypotheses.
Biliverdin reductase-A protein levels are reduced in type 2 diabetes and are associated with poor glycometabolic control.
Biliverdin reductase: a target for cancer therapy?
Early increase in blood supply (EIBS) is associated with tumor risk in the Azoxymethane model of colon cancer.
Human biliverdin reductase regulates the molecular mechanism underlying cancer development.
Human biliverdin reductase suppresses Goodpasture antigen-binding protein (GPBP) kinase activity: the reductase regulates tumor necrosis factor-alpha-NF-kappaB-dependent GPBP expression.
Overexpression of biliverdin reductase enhances resistance to chemotherapeutics.
The oxidoreductase, biliverdin reductase, is induced in human renal carcinoma--pH and cofactor-specific increase in activity.
Nephritis
Heme catabolism in human kidneys. Effect of various nephritides.
Neuroblastoma
Biliverdin reductase as a target in drug research and development: Facts and hypotheses.
Neurodegenerative Diseases
BVR-A Deficiency Leads to Autophagy Impairment through the Dysregulation of AMPK/mTOR Axis in the Brain-Implications for Neurodegeneration.
Oxidative and nitrosative modifications of biliverdin reductase-a in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment.
Neutropenia
A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408.
Nevus, Pigmented
The heme oxygenase/biliverdin reductase system in skin cancers.
Non-alcoholic Fatty Liver Disease
CRISPR Cas9-mediated deletion of biliverdin reductase A (BVRA) in mouse liver cells induces oxidative stress and lipid accumulation.
Reduced Biliverdin Reductase-A Expression in Visceral Adipose Tissue is Associated with Adipocyte Dysfunction and NAFLD in Human Obesity.
Obesity
Reduced Biliverdin Reductase-A Expression in Visceral Adipose Tissue is Associated with Adipocyte Dysfunction and NAFLD in Human Obesity.
Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity.
Persistent Infection
Rv2074 is a novel F420 H2 -dependent biliverdin reductase in Mycobacterium tuberculosis.
Pneumothorax
Induction of heme oxygenase-1, biliverdin reductase and H-ferritin in lung macrophage in smokers with primary spontaneous pneumothorax: role of HIF-1alpha.
Pulmonary Atresia
Biventricular Repair of Pulmonary Atresia After Fontan Palliation.
Renal Insufficiency
Low serum bilirubin in chronic renal failure. Relation to haem metabolism.
Sagittal Sinus Thrombosis
Venous transcranial Doppler in acute dural sinus thrombosis.
Sepsis
SEP-8: UPREGULATION OF BVR ACTIVITIES IN WHITE BLOOD CELLS OF PATIENTS WITH SIRS AND SEPSIS.
Skin Neoplasms
The heme oxygenase/biliverdin reductase system in skin cancers.
Stroke
Argatroban Increased the Basal Vein Drainage and Improved Outcomes in Acute Paraventricular Ischemic Stroke Patients.
Direct oral anticoagulants in patients with atrial fibrillation and bioprosthetic valve replacement: A meta-analysis.
Preserved cognition and functional independence after a large right posterior cerebral artery infarct: longitudinal clinical and neuropathological findings.
Subarachnoid Hemorrhage
Subarachnoid Hemorrhage Increases Level of Heme Oxygenase-1 and Biliverdin Reductase in the Choroid Plexus.
Tachycardia, Ventricular
Beat-to-beat variability of repolarization: a new parameter to determine arrhythmic risk of an individual or identify proarrhythmic drugs.
Torsades de Pointes
Beat-to-Beat Variability in Preload Unmasks Latent Risk of Torsade de Pointes in Anesthetized Chronic Atrioventricular Block Dogs.
Tuberculosis
Rv2074 is a novel F420 H2 -dependent biliverdin reductase in Mycobacterium tuberculosis.
The molecular structure of Rv2074, a probable pyridoxine 5'-phosphate oxidase from Mycobacterium tuberculosis, at 1.6 angstroms resolution.
Varicose Veins
Dural Arteriovenous Fistula of the Sinus of the Lesser Sphenoid Wing Presenting with Pontine Hemorrhage.
Vascular Diseases
Translational Significance of Heme Oxygenase in Obesity and Metabolic Syndrome.
Ventricular Fibrillation
Motor Cortex and Hippocampus Display Decreased Heme Oxygenase Activity 2 Weeks After Ventricular Fibrillation Cardiac Arrest in Rats.
Selective chemical ablation of transient receptor potential vanilloid 1 expressing neurons in the left stellate ganglion protects against ischemia-induced ventricular arrhythmias in dogs.
Virus Diseases
Rapamycin inhibition of baculovirus recombinant (BVr) ribosomal protein S6 kinase 1 (S6K1) is mediated by an event other than phosphorylation.